leisure time -WSS

leisure time

author：focus 2025-09-30 16:28:28 - browse：9574

An eye emerges from lines of binary codes — health tech coverage from STAT — Adobe

Investors are starting to back startups that offer privacy and security services to bolster health AI products already on the market while they wait for crucial safety and privacy regulations to take shape.

Though health leaders are racing to deploy generative AI products that can automatically transcribe doctor-patient conversations during medical appointments or churn through massive repositories of scientific research, they’re still flummoxed about how to measure their quality. Cybersecurity experts have warned that indiscriminately hooking third-party apps up to health system networks could expose sensitive data to hackers as ransomware attacks surge, and regulators and industry groups are rushing to set standards for responsible AI use.

Several government agencies and industry groups are working on rules and recommendations for avoiding bias and safety hazards within medical AI, but hospitals and startups are still in the dark about what exactly those will require and who’ll eventually be liable for any harm caused. It could be months, or even years, before these overlapping rules from multiple federal agencies are in place, and those rules might still change as the technology evolves.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： ASCO Daily Recap: CAR

focus

WSS

Menendez indictment could see pharma lose a key ally

Medicaid, Medicare dual

Inequities make cancer less preventable for women: report

Biogen shutters digital health group, ends Apple study, in cost cutting move

Health tech startups drop sharply from 2021 highs

For pregnant people, addiction treatment shouldn't mean a call to child protective services

Wikipedia

leisure time

focus

Sports medicine is finally prioritizing gender equality

Menendez indictment could see pharma lose a key ally

Medical leaders decry Supreme Court decision on affirmative action

Medicare Advantage's lean provider networks lead CMS complaints

Medicare details structure of new drug price negotiation program

After a drawn out lobbying fight, ARPA

Duchenne breakthrough therapy leaves behind pioneering families

Listen: Who gets the credit for GLP

Tori Bowie and the unacceptable rates of Black maternal death

UnitedHealth CEO's Medicaid comments send insurer stocks diving

entertainment

FDA approves Moderna’s RSV vaccine, its second licensed product

Medicaid, Medicare dual

Why do women spend more than men on medical expenses?

Paxlovid should be available without a positive Covid test

Take antibiotics after sex, CDC recommends for certain risk groups

Anthony Fauci pushes back on GOP claims during Covid hearing

hotspot

hotspot

focus

knowledge